American Healthcare REIT(US:AHR) Prnewswire·2026-02-26 21:15Core Insights - American Healthcare REIT, Inc. (AHR) reported strong financial results for Q4 2025 and the full year 2025, with significant growth in Same-Store Net Operating Income (NOI) and Normalized Funds from Operations (NFFO) per share [1][2] Financial Performance - AHR achieved Same-Store NOI growth of 24.6% in its SHOP segment and 14.0% in its ISHC segment for Q4 2025 compared to Q4 2024 [1] - For the full year 2025, Same-Store NOI growth was 25.2% for SHOP and 18.4% for ISHC, contributing to a total portfolio Same-Store NOI growth of 14.2% [1] - NFFO per diluted share was reported at $0.46 for Q4 2025 and $1.72 for the full year 2025, marking over 20% growth compared to the previous year [2] Capital and Transactional Activity - The company completed over $950 million in acquisitions during 2025, with significant investments in both ISHC and SHOP segments [1] - AHR raised approximately $447.1 million through a forward follow-on common equity offering in November 2025 and issued additional shares under its ATM Program for gross proceeds of approximately $275.1 million [1][2] Guidance for 2026 - AHR issued guidance for 2026, projecting Same-Store NOI growth of 7.0% to 11.0% and NFFO per diluted share between $1.99 and $2.05 [1][2] - The company anticipates continued growth in its SHOP segment, which has been the fastest-growing segment over the last two years [2] Balance Sheet and Liquidity - As of December 31, 2025, AHR had total consolidated indebtedness of $1.54 billion and approximately $1.14 billion in total liquidity [1] - The company's Net Debt-to-Annualized Adjusted EBITDA ratio improved to 3.4x from 3.5x as of September 30, 2025 [1] Development Pipeline - AHR's in-process development and expansion pipeline is expected to cost approximately $178.0 million, with $66.9 million funded as of December 31, 2025 [1]